Signal active
Bio
Michael E Marks is the Founding Managing Partner at Celesta Capital. Prior to that, he was the CEO and founder of Katerra. He was also the founding partner of Riverwood Capital, a Menlo Park-based private equity firm. Prior to establishing Riverwood, he was a partner and senior advisor at Kohlberg Kravis Roberts & Co. in 2006 and 2007.
Prior to KKR, Michael spent 13 years as CEO and then chairman of Flextronics International Ltd., building it into one of the largest technology companies in the world.
He is a director of The Melt, Enjoy, H20.ai, and Berkeley Lights.
Location
Menlo Park, California, United States, North America
Social
Primary Organization
2013
171
90
17
11-50
Financial Services, Venture Capital, Financial Exchanges
Jobs history
7
Chairman of the Board
Invalid date - Current
Atonarp
Board Member
2021 - Current
Smartfrog Group
Board Member
Invalid date - Current
Canary
Board Member
Invalid date - Current
Whiterabbit.ai
Board Member
Invalid date - Current
Chairman of Board
Invalid date - Current
Celesta Capital
Founding Managing Partner
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Michael Marks is the Founding Managing Partner at Celesta Capital, based in United States, North America. With a background in Financial Services, Michael Marks has a rich history of leadership and innovation. Michael Marks studied B.A. Psychology @ Oberlin College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
10
2
Personal investment
10
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Nov 06, 2019 | Extend | Series A - Extend | 16.4M |
Aug 18, 2021 | EnTribe | Seed Round - EnTribe | 2.7M |
Sep 16, 2021 | Rizzle | Convertible Note - Rizzle | 17.0M |
Jan 14, 2022 | Home Delivery Service (HDS Global) | Venture Round - Home Delivery Service (HDS Global) | 5.0M |
Partner investment
16
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
May 17, 2022 | Very Good Ventures | Series A - Very Good Ventures | Celesta Capital | 3.0M |
Aug 10, 2022 | - | Series C - Prellis Biologics | Celesta Capital | 35.0M |
Jul 26, 2023 | Very Good Ventures | Series A - Very Good Ventures | Celesta Capital | 3.4M |
Jul 27, 2023 | Finicast | Seed Round - Finicast | Celesta Capital | 12.8M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.